Trupanion, Inc. (NASDAQ:TRUP) SVP Sells $170,035.00 in Stock

Trupanion, Inc. (NASDAQ:TRUP) SVP Emily Dreyer sold 3,100 shares of Trupanion stock in a transaction dated Friday, November 22nd. The shares were sold at an average price of $54.85, for a total value of $170,035.00. Following the completion of the sale, the senior vice president now directly owns 24,708 shares in the company, valued at $1,355,233.80. This represents a 11.15 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Emily Dreyer also recently made the following trade(s):

• On Monday, November 25th, Emily Dreyer sold 900 shares of Trupanion stock. The shares were sold at an average price of $54.55, for a total value of $49,095.00.

Trupanion Stock Performance

Shares of TRUP opened at $53.50 on Friday. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.66 and a quick ratio of 1.66. The firm has a 50-day moving average of $49.73 and a 200-day moving average of $40.06. The company has a market cap of $2.27 billion, a PE ratio of -167.19 and a beta of 1.69. Trupanion, Inc. has a one year low of $19.69 and a one year high of $57.90.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.09. The firm had revenue of $327.50 million for the quarter, compared to the consensus estimate of $321.79 million. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The business’s revenue was up 14.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.10) earnings per share. As a group, equities analysts forecast that Trupanion, Inc. will post -0.23 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Evercore ISI raised Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Northland Securities raised their target price on shares of Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research report on Thursday, October 31st. Bank of America boosted their price target on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research report on Friday, September 20th. Stifel Nicolaus raised their price objective on Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a report on Monday, September 23rd. Finally, Piper Sandler lifted their target price on Trupanion from $45.00 to $57.00 and gave the company a “neutral” rating in a research report on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $44.67.

Institutional Investors Weigh In On Trupanion

A number of large investors have recently added to or reduced their stakes in TRUP. State Board of Administration of Florida Retirement System increased its holdings in shares of Trupanion by 12.6% in the first quarter. State Board of Administration of Florida Retirement System now owns 12,726 shares of the financial services provider’s stock valued at $351,000 after purchasing an additional 1,420 shares during the last quarter. Vanguard Group Inc. raised its holdings in Trupanion by 0.9% in the 1st quarter. Vanguard Group Inc. now owns 3,673,791 shares of the financial services provider’s stock valued at $101,433,000 after acquiring an additional 32,485 shares during the period. CANADA LIFE ASSURANCE Co lifted its position in Trupanion by 2.0% during the first quarter. CANADA LIFE ASSURANCE Co now owns 43,060 shares of the financial services provider’s stock worth $1,188,000 after acquiring an additional 830 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in shares of Trupanion by 14.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 11,325 shares of the financial services provider’s stock worth $313,000 after acquiring an additional 1,441 shares during the period. Finally, Bayesian Capital Management LP acquired a new position in shares of Trupanion in the first quarter valued at approximately $253,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.